OptiBiotix replaces Commercial Director

OptiBiotix Health is rearranging its directorial staff as it has changed its Commercial Director. Namely, Jim Laird will be substituted by Per Rehné to that directorial position.

The company that makes products to tackle obesity, high cholesterol, diabetes and skin care has in Per a person with experience in the food industry, having worked for some of the world’s leading food companies including Danisco, which was bought by Dupont in 2011 for $6.3billion. He was also Managing Director of Frutarom Nordic and Innotaste Nordic A/S.  Per has made Health and Nutrition at Cornelius Group the company’s fastest growing business unit, quadrupling sales from a low base to double digit million pound revenues in less than three years, where he was a European Director.

Per is a qualified food technologist and is multilingual in English, Danish, German, Swedish and Norwegian.  His experience of food, health, and nutrition markets will help drive commercialisation of OptiBiotix’s growing pipeline of products and create multiple revenue streams across all technology platforms, the company said.

Stephen O’Hara, CEO of OptiBiotix, commented: “Per’s experience and track record of growing business-to-business sales of ingredients and nutritional products brings operational commercial and industry expertise to OptiBiotix. His network of contacts provides access to new international markets to help drive revenue growth from OptiBiotix’s growing pipeline of products now entering their commercialisation phase. These include OptiBiotix’s patented SlimBiome technology for hunger free weight loss and its LP-LDL probiotic strain for cholesterol and hypertension reduction. This is consistent with the overall aim of developing multiple revenue streams from both consumer and pharmaceutical products across all OptiBiotix’s technology platforms. On behalf of the Board, I would like to thank Jim for his hard work and dedication to the Company and we wish him well in his future projects.”